产品展示

Anti-CD163 antibody [EPR19518] (ab182422) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt, IHC-Fr IHC-P, WB and mIHC.

Anti-CD163 antibody [EPR19518] (ab182422) was first used in a scientific publication in 2014 and has been cited over 399 times in peer reviewed journals. It's performance in IHC in human, mouse and rat samples is trusted by the scientific community.

Abcam's high quality manufacturing and validation processes ensure Anti-CD163 antibody [EPR19518] (ab182422) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.

Anti-CD163 antibody [EPR19518] (ab182422) has 17 independent reviews from customers.

Anti-CD163 antibody [EPR19518] (ab182422) specifically detects CD163 (UniProt ID: Q2VLH6; Molecular weight: 118kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).

Conjugation-ready, carrier free format available for antibody clone EPR19518 - ab213612.

Antibody clone EPR19518 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 555, Alexa Fluor® 594, Alexa Fluor® 488, Alexa Fluor® 647, Biotin, PE (ab281746, ab282114, ab313665, ab313666, ab314941, ab314947).

Recombinant antibody to CD163 is involved in conditions like rheumatoid arthritis and atherosclerosis, where it helps regulate inflammation. Top cited clone on the market

Patented technologyOur RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?This product is a recombinant monoclonal antibody, which offers several advantages including:

• - High batch-to-batch consistency and reproducibility
• - Improved sensitivity and specificity
• - Long-term security of supply
• - Animal-free batch production